Selection of Patients for Carotid Revascularization
Jump to navigation
Jump to search
|
Carotid artery stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
ACC/AHA Guideline Recommendations |
|
Periprocedural Management of Patients Undergoing Carotid Endarterectomy |
|
Atherosclerotic Risk Factors in Patients With Vertebral Artery Disease |
|
Occlusive Disease of the Subclavian and Brachiocephalic Arteries |
|
Case Studies |
|
Selection of Patients for Carotid Revascularization On the Web |
|
American Roentgen Ray Society Images of Selection of Patients for Carotid Revascularization |
|
Selection of Patients for Carotid Revascularization in the news |
|
Blogs on Selection of Patients for Carotid Revascularization |
|
Risk calculators and risk factors for Selection of Patients for Carotid Revascularization |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Selection of Patients for Carotid Revascularization
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease (DO NOT EDIT)[1]
Recommendations for Selection of Patients for Carotid Revascularization
| Class I |
| "1. Patients at average or low surgical risk who experience nondisabling ischemic stroke† or transient cerebral ischemic symptoms, including hemispheric events or amaurosis fugax, within 6 months (symptomatic patients) should undergo CEA if the diameter of the lumen of the ipsilateral internal carotid artery is reduced more than 70%‡ as documented by noninvasive imaging (Level of Evidence: A)" or more than 50% as documented by catheter angiography (Level of Evidence: B)" and the anticipated rate of perioperative stroke or mortality is less than 6%. |
| "2. CAS is indicated as an alternative to CEA for symptomatic patients at average or low risk of complications associated with endovascular intervention when the diameter of the lumen of the internal carotid artery is reduced by more than 70% as documented by noninvasive imaging or more than 50% as documented by catheter angiography and the anticipated rate of periprocedural stroke or mortality is less than 6% (Level of Evidence: B)" |
| "3. Selection of asymptomatic patients for carotid revascularization should be guided by an assessment of comorbid conditions, life expectancy, and other individual factors and should include a thorough discussion of the risks and benefits of the procedure with an understanding of patient preferences. (Level of Evidence: C)" |
| Class III (Harm) |
| "1. Except in extraordinary circumstances, carotid revascularization by either CEA or CAS is not recommended when atherosclerosis nar- rows the lumen by less than 50% (Level of Evidence: A) " |
| "2. Carotid revascularization is not recommended for patients with chronic total occlusion of the targeted carotid artery. (Level of Evidence: C) " |
| "3. Carotid revascularization is not recommended for patients with severe disability¶ caused by cerebral infarction that precludes preservation of useful function. (Level of Evidence: C) " |
| Class IIa |
| "1. It is reasonable to perform CEA in asymptomatic patients who have more than 70% stenosis of the internal carotid artery if the risk of perioperative stroke, MI, and death is low (Level of Evidence: A) " |
| "2. It is reasonable to choose CEA over CAS when revascularization is indicated in older patients, particularly when arterial pathoanatomy is unfavorable for endovascular intervention. (Level of Evidence: B) " |
| "3. It is reasonable to choose CAS over CEA when revascularization is indicated in patients with neck anatomy unfavorable for arterial surgery (Level of Evidence: B) " |
| "4. When revascularization is indicated for patients with TIA or [stroke] and there are no contraindications to early revascularization, intervention within 2 weeks of the index event is reasonable rather than delaying surgery (Level of Evidence: B) " |
| Class IIb |
| "1. Prophylactic CAS might be considered in highly selected patients with asymptomatic carotid stenosis (minimum 60% by angiogra- phy, 70% by validated Doppler ultrasound), but its effectiveness compared with medical therapy alone in this situation is not well established (Level of Evidence: B) " |
| "2. In symptomatic or asymptomatic patients at high risk of complications for carotid revascularization by either CEA or CAS because of comorbidities, the effectiveness of revascularization versus medi- cal therapy alone is not well established (Level of Evidence: B) " |
References
- ↑ Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL; et al. (2011). "2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery". Circulation. 124 (4): 489–532. doi:10.1161/CIR.0b013e31820d8d78. PMID 21282505.